PDCD1 and neoplasm: Tumor cells can regulate the proliferation and differentiation of macrophages to the M2 type with the help of class IIa HDACs (26); thus, TMP195, an HDAC inhibitor, can reduce the number of M2 macrophages in mice and improve the efficacy and tolerability of chemotherapy and PD-1 inhibitors (27).